US Stock MarketDetailed Quotes

OMER Omeros

Watchlist
  • 11.210
  • +1.370+13.92%
Close Jan 3 16:00 ET
  • 11.160
  • -0.050-0.45%
Post 20:01 ET
649.62MMarket Cap-4.87P/E (TTM)

Omeros Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Omeros Q3 2024 Earnings Date

Currency：USDNov 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
EPS
-0.70
-0.56
+0.14
Beat Est.
-17.50%
+6.67%
+20.56%
Net Income
--
-32.23M
--
+14.62%
Analyst Rating
Buy

Dec 23, 2024

Omeros Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
Nov 13, 20242024/Q30.000 / 0.000--
Aug 7, 20242024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
Nov 13, 20242024/Q30.000 / 0.000--
Aug 7, 20242024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Omeros Earnings Reports

  • Omeros | 10-Q: Q3 2024 Earnings Report

    Nov 13, 2024 16:14 ET

  • Omeros | 8-K: Omeros Corporation Reports Third Quarter 2024 Financial Results – Conference Call Today at 4:30 p.m. ET

    Nov 13, 2024 16:13 ET

  • Omeros | 10-Q: Q2 2024 Earnings Report

    Aug 7, 2024 16:15 ET

  • Omeros | 8-K: Omeros Corporation Reports Second Quarter 2024 Financial Results – Conference Call Today at 4:30 p.m. ET

    Aug 7, 2024 16:13 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    DexCom
    DXCM
    +3.27%
    Collegium Pharmaceutical
    COLL
    +3.07%
    Lantheus
    LNTH
    +2.71%
    Cars.com
    CARS
    +1.72%
    YETI Holdings
    YETI
    +1.60%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 23, 2024

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday+1.19%